Global Blood Cancer Drugs Market Outlook, 2020-2030 – Amgen, AstraZeneca, Bayer, Celgene, and Eli Lilly are Dominating

Dublin, March 06, 2020 (GLOBE NEWSWIRE) — The “Blood Cancer Drugs Global Market Report 2020” report has been added to ResearchAndMarkets.com’s offering.LeukemiaLymphomaMyeloma4.2. Global Blood Cancer Drugs Market, Segmentation by Drugs, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ BillionRituaxan/Mabthera (Rituximab)Gleevac/Glivec (Imatinib)Revlimid (Lenalidomide)Velcade (Bortezomib)Tasigna (Nilotinib)Pomalyst (Pomalidomide)Vidaza (Azacitidine)Kyprolis (Carfilzomib)Adcetris (Brentuximab Vedotin)Others5. Blood Cancer Drugs Market Regional and Country Analysis
5.1. Global Blood Cancer Drugs Market, Split by Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
5.2. Global Blood Cancer Drugs Market, Split by Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ BillionAbbVie Inc.Amgen Inc.Astellas Pharma Inc.AstraZeneca PLCBayer AGBristol-Myers Squibb CompanyCelgene CorporationEli LillyF.Hoffmann-La Roche Ltd.GlaxoSmithKline Pharmaceuticals Ltd.Johnson & JohnsonMerck and CompanyNovartisPfizer Inc.Roche Holding AGTakeda Pharmaceutical Company Ltd.For more information about this report visit https://www.researchandmarkets.com/r/tuytomResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research.CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900